Cue Biopharma
Price & Volume
Stats
See more52W Range | $0.45-$3.24 |
Market Cap | $77.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $8.2M |
Revenue Growth (YoY) | 92.3% |
Gross Profit (12 Mos) | $1.2M |
Diluted EPS | -$0.91 |
News
See moreYahoo Finance • last year
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
Yahoo Finance • last year
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
Yahoo Finance • last year
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
Yahoo Finance • last year
Cue Biopharma to Host Business Update Call and Webcast
About
CEO | Mr. Daniel R. Passeri J.D., M.Sc. |
Address | 40 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 53 |
